# Heterogeneity in biological, physical, and cognitive aging in older breast cancer survivors and controls

> **NIH NIH R56** · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2021 · $885,747

## Abstract

PROJECT SUMMARY
The past two decades have witnessed dramatic advances in our understanding of aging processes, with data
demonstrating heterogeneity in biological, functional, and cognitive aging. Understanding this heterogeneity,
and factors that influence aging, has important implications for the clinical care of older individuals. Cancer is a
leading disease of older age, second only to cardiovascular disease, and cancer has been suggested as a
disease driver of aging. Heterogeneity in physical and cognitive functional changes suggests that there are
important modifiers to the aging processes. However, significant gaps in knowledge remain, including how
rates of aging differ among survivors vs. non-cancer populations, whether rates of biological aging explain
observed heterogeneity in physical and cognitive function, and what are the potential modifiable factors that
could be a clinical survivorship intervention target. The current proposed research will directly address the NIA
mission to understand the clinical and biological nature of the aging process, the role that cancer treatment
plays in this process, and identify targets for extending healthy years of life.
The goals of the current study are to 1) compare longitudinal biological aging in older breast cancer survivors
to non-cancer controls, 2) determine whether physical and cognitive functional declines are greater in survivors
than controls and whether biological aging mediates this effect, and 3) evaluate the impact of sleep
disturbances, a modifiable behavior, on aging patterns. We will leverage a cohort of 368 survivors and similar
numbers of age-, race-, education-, and site- frequency-matched non-cancer controls enrolled pre-systemic
treatment/enrollment and complete annual follow up visits through 36-months, using biospecimens collected at
annual visits to measure biological aging. This study offers an extraordinary opportunity to efficiently address
whether and how cancer and its treatments accelerate aging and will provide important new data about
clinically important aging outcomes.

## Key facts

- **NIH application ID:** 10490504
- **Project number:** 1R56AG068086-01A1
- **Recipient organization:** UNIVERSITY OF CALIFORNIA LOS ANGELES
- **Principal Investigator:** Judith E Carroll
- **Activity code:** R56 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $885,747
- **Award type:** 1
- **Project period:** 2021-09-30 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10490504

## Citation

> US National Institutes of Health, RePORTER application 10490504, Heterogeneity in biological, physical, and cognitive aging in older breast cancer survivors and controls (1R56AG068086-01A1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10490504. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*